In this issue:
Corticosteroids and worse outcomes with COVID-19
Poor drug sustainability with thiopurines in IBD
Anti-TNF induction +/- corticosteroids in CD
Risk of intestinal and extraintestinal cancers in IBD
Luminal microbiota-related CD recurrence post surgery
Biologic safety in the immediate post-operative period
Medical therapy for fibrostenosing CD
Early discontinuation of infliximab in pregnant women
IBD blog: Sexual function and fertility in men with IBD
Virtual vs standard clinic for anti-TNF treat-to-target in CD
Mediterranean diet and risk of later-onset IBD
Please login below to download this issue (PDF)